BIOA BioAge Labs, Inc.

bullish · high conviction track record → $18.71 -0.43 (-2.2%)
Mkt Cap $848M 52wk $3.67 - $24.00 2h ago
Insider buying: $47,930,365 bought by 9 insiders (30d)
Est. revisions: +5.1% (2 up, 1 down in 30d)
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net +1.9)

Factor Model

net +1.9
Est. Revisions
+0.3
Insider Activity
+0.5
Momentum
+0.0
Analyst Rev.
+0.6
Narrative Gap
+0.0

Strong Insider Buys Lift BioAge Labs Momentum

Watch: Watch upcoming earnings and pipeline updates for validation of growth acceleration and margin improvement progress.

BioAge Labs insiders bought over $47 million in shares at prices near $18 and up to nearly $20 per share. BTIG initiated coverage with a Buy rating and a $40 price target versus a $18.19 close. Institutional owners like Citadel and Renaissance hold notable stakes amid accelerating revenue momentum, despite lingering operating losses.

Insider buying and analyst initiation signal growing confidence in BioAge's turnaround potential and market positioning, possibly foreshadowing share price recovery and improved fundamentals.

Evidence

1d ago Insider buy by PANDE VIJAY SATYANAND PH.D. (BIOA): $4,329,019
1d ago Insider buy by ENRIGHT PATRICK G. (BIOA): $7,200,000
1d ago Insider buy by CORMORANT ASSET MANAGEMENT ,L.P (BIOA): $8,100,000
1d ago Insider buy by HEMRAJANI REKHA (BIOA): $54,000
1d ago Insider buy by HEALY JAMES I (BIOA): $11,999,970
1d ago Insider buy by BARTON SHANE (BIOA): $47,376
1d ago Insider buy by PANDE VIJAY SATYANAND PH.D. (BIOA): $16,200,000
1d ago BTIG init BIOA: Buy
2 older signals
2d ago This CoinShares Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Wednesday
45d ago BGE-102 Data Inspires Confidence for BioAge Labs (BIOA)
Fundamentals & Data ▾
BioAge Labs, Inc. Healthcare · Drug Manufacturers - Specialty & Generic
Mkt Cap
$848M
52w Range
$3.67 - $24.00
Short Interest
1.9M 4.8%
Days to Cover
4.4 +21%
Technicals downtrend
from 52w Hi
-2.2%
1w return
+5.0%
Insiders
selling 3B / 7S
Analysts
bullish 1 up / 0 down
EPS Estimate
$-0.61 +5.1% 30d 2up / 1dn
Est. Dispersion
23% 4 analysts
Analyst Target
$53 $23 - $73
Options P/C
13.89
Insider Cluster
strong buy 6B / 3S
Fund Convergence
strong Citadel, Renaissance, Two Sigma
Financials
Revenue
$3M
FCF
$-28M
Op Margin
-923%
Momentum: accelerating
Top Holders
Citadel $3M
Renaissance $2M
Two Sigma
Recent Filings & Data
insider trade 26
net buying · $6,215,606 sold · $47,930,365 bought
9 insiders · 26 transactions (30d)
Recent transactions
GOLDSTEIN DOV A · exercise · $15,514
RUBIN PAUL D · sell · $157,084
RUBIN PAUL D · exercise · $44,572
RUBIN PAUL D · sell · $150,890
RUBIN PAUL D · exercise · $35,470
RUBIN PAUL D · sell · $139,369
GOLDSTEIN DOV A · exercise · $15,510
GOLDSTEIN DOV A · sell · $531,828
GOLDSTEIN DOV A · exercise · $226,530
FORTNEY KRISTEN PH.D. · sell · $4,223,036
RUBIN PAUL D · sell · $95,490
RUBIN PAUL D · sell · $216,000
RUBIN PAUL D · exercise · $118,260
RUBIN PAUL D · sell · $701,909
RUBIN PAUL D · exercise · $283,167
PANDE VIJAY SATYANAND PH.D. · buy · $4,329,019
ENRIGHT PATRICK G. · buy · $7,200,000
ENRIGHT PATRICK G. · other
CORMORANT ASSET MANAGEMENT ,L.P · buy · $8,100,000
CORMORANT ASSET MANAGEMENT ,L.P · other
HEMRAJANI REKHA · buy · $54,000
HEALY JAMES I · buy · $11,999,970
HEALY JAMES I · other
BARTON SHANE · buy · $47,376
PANDE VIJAY SATYANAND PH.D. · buy · $16,200,000
PANDE VIJAY SATYANAND PH.D. · other
analyst rating 1
BTIG init → Buy 2d ago
10 signals · latest 1d ago

Keep reading the market

Direction shifts, insider clusters, filing red flags, and earnings call changes stay published on the site.

All stocks → Track record → How it works →